Freep readers weigh in on Mitch Albom's latest column, and GM's plan to demo two towers of the Renaissance Center in Detroit.

Experts have only themselves to blame for the distrust of institutions. Now they tell us.

Researchers have identified antibodies that could lead to a broadly protective norovirus vaccine and new treatment options.

Now they tell us. “We were badly misled about the event that changed our lives.” So reads the headline on Princeton professor Zeynep Tufekci’s March 16 article in The New York Times. The event was, of ...

NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

How Infectious Disease Doctors Can Keep Up in a Rapidly Evolving Field As with most areas of medicine, advances in infectious diseases are accelerating at a rapid clip, and it’s understandable that as ...

Fred Hutch virologist Keith Jerome, MD, PhD, and evolutionary biologist Jesse Bloom, PhD, were recently elected to the 2025 ...

Researchers evaluated the potential clinical impact and cost-effectiveness of administering long-acting, injectable ...

Appili Therapeutics (APLIF) announced that, the Company along with its partners, have submitted applications for four new federal funding ...

President Donald Trump shared a conspiracy theory that claims Jan. 6 investigation committee pardons are void because Biden ...

Older adults who were exposed to seasonal flu viruses that circulated prior to 1968 are more likely to have some protection against H5N1, and children would benefit more from H5N1 vaccines.